This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Align Technology, based in California, manufactures and markets a system of clear aligner therapy, intra-oral scanners and CAD/CAM (computer-aided design and computer-aided manufacturing) digital services used in dentistry, orthodontics, and dental records storage. The clear aligner system corrects malocclusion using nearly invisible and removable appliances that gently move the tooth to a desired final position.
Reasons to Hold on to Align Technology (ALGN) Stock for Now
by Zacks Equity Research
Investors continue to be optimistic about Align Technology (ALGN) on solid customer adoption of Invisalign and iTero products.
Stock Market News for Apr 12, 2021
by Zacks Equity Research
Benchmarks hit record levels on Friday, closing in the green for consecutive weeks as investors shrugged off inflation fears and focused on quarterly earnings season amid reopening optimism
Why the National Debt is Irrelevant: John Oliver is Funnier, But We Reach Same Conclusion
by Kevin Cook
Old crystal balls for viewing fiscal discipline never foresaw this golden age of tech innovation and ultra-low inflation.
BD's (BDX) $65M Investment to Boost Supply-Chain Strength
by Zacks Equity Research
BD's (BDX) $65-million investment in constructing an advanced facility will become integral to the U.S. medical device supply chain.
Here's Why You Should Retain Luminex (LMNX) Stock for Now
by Zacks Equity Research
Investor confidence is high in Luminex (LMNX) stock, courtesy of its solid prospects.
Zimmer Biomet (ZBH) Enhances ZBEdge Portfolio With Latest Suite
by Zacks Equity Research
Zimmer Biomet's (ZBH) latest portfolio enhancement is aimed at improving patient outcome throughout the entire treatment process.
Omnicell's (OMCL) 2025 Roadmap Impressive, Pandemic Woe Stays
by Zacks Equity Research
Omnicell (OMCL) expands its autonomous pharmacy portfolio with the acquisition of PSG's 340B Link business.
Here's Why You Should Hold on to Medtronic (MDT) Stock for Now
by Zacks Equity Research
Investors continue to be optimistic about Medtronic (MDT) on its slew of product launches and regulatory approvals.
Is Align Technology (ALGN) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Is (ALGN) Outperforming Other Medical Stocks This Year?
Walgreens Boots (WBA) Q2 Earnings Top Estimates, Margins Down
by Zacks Equity Research
Walgreens Boots' (WBA) fiscal second-quarter results reflect overall top-line improvement despite COVID-19-led business disruptions.
Reasons to Hold on to Syneos Health (SYNH) Stock For Now
by Zacks Equity Research
Investors continue to be optimistic about Syneos Health (SYNH) on solid sequential recovery of its operating segments and strategic partnerships.
AngioDynamics (ANGO) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
AngioDynamics (ANGO) witnesses revenue growth across two business segments in fiscal Q3.
Align Technology (ALGN) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Align Technology (ALGN) closed at $524.33 in the latest trading session, marking a +1.61% move from the prior day.
Late-Breaking Data Supports Boston Scientific's (BSX) TheraSphere
by Zacks Equity Research
Boston Scientific's (BSX) TheraSphere is expected to be used as a safe and effective treatment option for numerous HCC patients worldwide on the back of positive trial results.
Here's Why You Should Retain Henry Schein (HSIC) Stock For Now
by Zacks Equity Research
Investors continue to be optimistic about Henry Schein (HSIC) on robust sales of PPE and COVID-19-related products.
PerkinElmer's (PKI) Horizon Discovery Broadens Portfolio
by Zacks Equity Research
PerkinElmer's (PKI) CRISPRi will help scientists get a firmer foothold in the biological pathways, processes and pathologies of disease.
Software is the New Gold: Storing Value in the Digital-Crypto Age
by Kevin Cook
Time for the final nail in the gilded sarcophagus of the barbarous relic.
Cardinal Health (CAH) Hits New 52-week High: What's Driving It?
by Zacks Equity Research
Cardinal Health (CAH) is witnessing an uptrend in its stock price, prompted by robust performance in both Pharmaceutical and Medical segments during the fiscal second quarter.
Why You Should Retain Varian (VAR) in Your Portfolio Now
by Zacks Equity Research
Investor optimism is high on the Varian (VAR) stock, courtesy of its solid prospects.
The Zacks Analyst Blog Highlights: L Brands, Align Technology, Diamondback Energy, The Mosaic Co and Capital One Financial
by Zacks Equity Research
The Zacks Analyst Blog Highlights: L Brands, Align Technology, Diamondback Energy, The Mosaic Co and Capital One Financial
Why You Should Add DENTSPLY SIRONA (XRAY) to Your Portfolio
by Zacks Equity Research
Investor confidence is high in the DENTSPLY SIRONA (XRAY) stock, thanks to solid prospects.
5 Top-Ranked Winners of Wall Street Since the Pandemic Trough
by Nalak Das
We have narrowed down our search to five large-cap stocks that have skyrocketed more than 150% in the past year. These are: LB, MOS, COF, ALGN and FANG.
The Zacks Analyst Blog Highlights: Etsy, L Brands, Diamondback Energy, Align Technology and Tapestry
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Etsy, L Brands, Diamondback Energy, Align Technology and Tapestry
Zacks.com featured highlights include: Align Technology, Etsy, 1st Constitution Bancorp, PotlatchDeltic and Williams-Sonoma
by Zacks Equity Research
Zacks.com featured highlights include: Align Technology, Etsy, 1st Constitution Bancorp, PotlatchDeltic and Williams-Sonoma
5 Top-Ranked Momentum Stocks Driven by Driehaus Strategy
by Nitish Marwah
The Driehaus strategy can be used to choose the best momentum stocks using the "buy high and sell higher" theory.